시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
안구건조증 치료 시장 규모, 점유율, 성장 분석 : 유형별, 약품별, 제품별, 제형별, 판매채널별, 지역별 - 산업 예측(2025-2032년)
Dry Eye Syndrome Treatment Market Size, Share, Growth Analysis, By Type, By Drugs, By Product, By Dosage Form, By Sales Channel, By Region - Industry Forecast 2025-2032
상품코드 : 1630642
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2025년 01월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,668,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,970,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,272,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 안구건조증 치료 시장 규모는 2023년에 70억 7,000만 달러로 평가되며, 예측 기간(2025-2032년)의 CAGR은 7.0%로, 2024년 75억 6,000만 달러에서 2032년에는 130억 달러로 성장할 전망입니다.

세계의 안구건조증 치료제 시장은 유병률 증가와 고령화 추세로 인해 강력한 성장세를 보이고 있습니다. 인식 개선, 진단 툴의 기술 발전, 환자 편의성 중시 등이 시장 성장을 촉진하고 있습니다. 주요 치료 옵션은 인공눈물, 항염증약, 면역조절제 등 의약품을 통한 중재입니다. 또한 안구건조증의 근본적인 원인을 해결할 것으로 기대되는 재생의학 및 유전자 치료와 같은 혁신적인 치료법에 대한 관심도 높아지고 있습니다. 연구개발이 강화됨에 따라 시장은 지속적으로 성장하고, 치료 효과를 높이고 환자의 예후를 개선할 수 있는 여건이 마련되고 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

안구건조증 치료 시장 규모 : 유형별

안구건조증 치료 시장 규모 : 약품별

안구건조증 치료 시장 규모 : 제품별

안구건조증 치료 시장 규모 : 제형별

안구건조증 치료 시장 규모 : 판매채널별

안구건조증 치료 시장 규모 : 유통 채널별

안구건조증 치료 시장 규모

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Global Dry Eye Syndrome Treatment Market size was valued at USD 7.07 billion in 2023 and is poised to grow from USD 7.56 billion in 2024 to USD 13.0 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

The global dry eye syndrome treatment market is experiencing robust growth, driven by the rising prevalence of the condition and an aging population. Increased awareness, coupled with technological advancements in diagnostic tools, and a focus on patient comfort, are propelling market expansion. The primary treatment options remain pharmaceutical interventions, such as artificial tears, anti-inflammatory drugs, and immunomodulators. Additionally, there's a growing trend towards innovative therapies, including regenerative medicine and gene therapy, which hold promise for addressing the root causes of dry eye syndrome. As research and development efforts intensify, the market is poised for continued growth, enhancing treatment efficacy and improving patient outcomes in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dry Eye Syndrome Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dry Eye Syndrome Treatment Market Segmental Analysis

Global Dry Eye Syndrome Treatment Market is segmented by Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel and region. Based on Type, the market is segmented into Evaporative Dry Eye Syndrome and Aqueous Deficient Dry Eye Syndrome. Based on Drugs, the market is segmented into Xiidra, Restasis, Cequa, Tyrvaya, Eysuvis and Others. Based on Product, the market is segmented into Artificial Tears, Cyclosporine, Topical Corticosteroids, Punctal Plugs, Oral Omega Supplements and Others. Based on Dosage Form, the market is segmented into Eye Drops/ Solutions, Ointments and Gels, Capsules & Tablets (For Supplements) and Other Dosage Forms. Based on Sales Channel, the market is segmented into Prescription, OTC and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dry Eye Syndrome Treatment Market

The global dry eye syndrome treatment market is experiencing significant growth driven by several factors contributing to the rising incidence of dry eye syndrome (DES) worldwide. Increased screen time associated with digital technology usage, an aging population, environmental pollution, and changing lifestyles have all significantly heightened the occurrence of DES. Consequently, this has led to a surge in demand for effective and innovative treatment solutions such as artificial tears, anti-inflammatory medications, and punctal plugs. This growing awareness and need for advanced therapeutic options are crucial in facilitating the expansion of the dry eye syndrome treatment market on a global scale.

Restraints in the Global Dry Eye Syndrome Treatment Market

The global dry eye syndrome treatment market faces a significant challenge due to the absence of a universal treatment solution. This condition is multifaceted, with various underlying causes such as aqueous deficiency and evaporative dysfunction, which results in a wide disparity in treatment effectiveness among patients. This variability often leads to extensive trial and error for individuals, causing frustration and delays in achieving relief. Furthermore, the complexity of dry eye syndrome complicates the pharmaceutical industry's efforts to create new therapies tailored to the distinct needs of each patient, ultimately hindering the potential growth of the market.

Market Trends of the Global Dry Eye Syndrome Treatment Market

The Global Dry Eye Syndrome Treatment market is increasingly shifting towards preservative-free eye drops and artificial tears, driven by a heightened awareness of the adverse effects associated with conventional preservatives. This trend reflects a broader consumer demand for safer, more effective therapeutic options that minimize irritation and enhance comfort for patients suffering from this chronic condition. As a result, pharmaceutical companies are investing in the development of innovative preservative-free formulations, aligning with patient preferences and regulatory pushes for safer healthcare products. Additionally, this trend is bolstered by the rising incidence of dry eye syndrome due to lifestyle factors, creating a robust market opportunity.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Dry Eye Syndrome Treatment Market Size by Type & CAGR (2025-2032)

Global Dry Eye Syndrome Treatment Market Size by Drugs & CAGR (2025-2032)

Global Dry Eye Syndrome Treatment Market Size by Product & CAGR (2025-2032)

Global Dry Eye Syndrome Treatment Market Size by Dosage Form & CAGR (2025-2032)

Global Dry Eye Syndrome Treatment Market Size by Sales Channel & CAGR (2025-2032)

Global Dry Eye Syndrome Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Global Dry Eye Syndrome Treatment Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기